These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 3338025)

  • 41. Comparison of transillumination and histologic slide measurements of tumor diameter in uveal melanoma.
    Polivogianis L; Seddon JM; Glynn RJ; Gragoudas ES; Albert DM
    Ophthalmology; 1988 Nov; 95(11):1576-82. PubMed ID: 3062526
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Biologic distinctions between cure and time to death in 2892 patients with intraocular melanoma.
    Gamel JW; McLean IW; McCurdy JB
    Cancer; 1993 Apr; 71(7):2299-305. PubMed ID: 8453550
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Long-term Risk of Melanoma-Related Mortality for Patients With Uveal Melanoma Treated With Proton Beam Therapy.
    Lane AM; Kim IK; Gragoudas ES
    JAMA Ophthalmol; 2015 Jul; 133(7):792-6. PubMed ID: 25905597
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A reappraisal of the significance of largest basal diameter of posterior uveal melanoma.
    Damato B; Coupland SE
    Eye (Lond); 2009 Dec; 23(12):2152-60; quiz 2161-2. PubMed ID: 19876071
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [The hierarchization of the prognostic factors in uveal malignant melanoma].
    Călugăru M; Mera M; Călugăru D
    Oftalmologia; 2000; 50(1):30-4. PubMed ID: 11021104
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Microvascular loops and networks as prognostic indicators in choroidal and ciliary body melanomas.
    Mäkitie T; Summanen P; Tarkkanen A; Kivelä T
    J Natl Cancer Inst; 1999 Feb; 91(4):359-67. PubMed ID: 10050870
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Surgical management of orbital malignant melanoma: our experience and a report of three cases].
    Poli T; Mora P; Reichegger V; Ricci R; Corradi D; Gandolfi SA; Sesenna E
    Klin Monbl Augenheilkd; 2007 Oct; 224(10):794-8. PubMed ID: 17952825
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [A case of exteriorized malignant ciliochoroidal melanoma in a negroid patient].
    Korobelnik JF; D'Hermies F; Frade P; Haye C; Schlienger P; Pouliquen Y
    J Fr Ophtalmol; 1989; 12(3):236-8. PubMed ID: 2695562
    [No Abstract]   [Full Text] [Related]  

  • 49. Human leukocyte antigen class I expression. Marker of poor prognosis in uveal melanoma.
    Blom DJ; Luyten GP; Mooy C; Kerkvliet S; Zwinderman AH; Jager MJ
    Invest Ophthalmol Vis Sci; 1997 Aug; 38(9):1865-72. PubMed ID: 9286277
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Uveal melanoma in the first 4 decades of life.
    Sagus M; Bedikian AY
    South Med J; 2015 Mar; 108(3):158-63. PubMed ID: 25772049
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prognostic value of the disodium phosphate 32P uptake test in uveal melanoma: a long-term study.
    Overkleeft EN; Zuidervaart W; Hurks HM; Eilers PH; de Wolff-Rouendaal D; Jager MJ
    Arch Ophthalmol; 2003 Oct; 121(10):1398-403. PubMed ID: 14557175
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of heterogeneous distribution of monosomy 3 on prognosis in uveal melanoma.
    Bronkhorst IH; Maat W; Jordanova ES; Kroes WG; Schalij-Delfos NE; Luyten GP; Jager MJ
    Arch Pathol Lab Med; 2011 Aug; 135(8):1042-7. PubMed ID: 21809997
    [TBL] [Abstract][Full Text] [Related]  

  • 53. JARID1B protein expression and prognostic implications in uveal melanoma.
    Radberger P; Radberger A; Bykov VJ; Seregard S; Economou MA
    Invest Ophthalmol Vis Sci; 2012 Jul; 53(8):4442-9. PubMed ID: 22669717
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Prognostic factors for uveal melanoma].
    Amiryan AG; Saakyan SV
    Vestn Oftalmol; 2015; 131(1):90-95. PubMed ID: 25872392
    [TBL] [Abstract][Full Text] [Related]  

  • 55. No differences in outcome between radical surgical treatment (enucleation) and stereotactic radiosurgery in patients with posterior uveal melanoma.
    Furdova A; Slezak P; Chorvath M; Waczulikova I; Sramka M; Kralik G
    Neoplasma; 2010; 57(4):377-81. PubMed ID: 20429631
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Iridocyclectomy. A review. Gleanings from the literature.
    Vail DT
    Am J Ophthalmol; 1971 Jan; 71(1 Pt 2):161-8. PubMed ID: 5100463
    [No Abstract]   [Full Text] [Related]  

  • 57. Clinical predictors of survival in metastatic uveal melanoma.
    Lorenzo D; Piulats JM; Ochoa M; Arias L; Gutiérrez C; Català J; Cobos E; Garcia-Bru P; Dias B; Padrón-Pérez N; Caminal JM
    Jpn J Ophthalmol; 2019 Mar; 63(2):197-209. PubMed ID: 30796549
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Uveal malignant melanoma in Israel (1970-1989)].
    Shargal Y; Pe'er J
    Harefuah; 1995 Nov; 129(10):369-74, 448. PubMed ID: 8647537
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Mortality from uveal melanoma treated by enucleation --a 16-year survey in Taiwan.
    Liu YC; Tsai CC; Lee FL; Lee SM; Kao SC
    Acta Ophthalmol; 2013 Nov; 91(7):e583-4. PubMed ID: 24131706
    [No Abstract]   [Full Text] [Related]  

  • 60. Posterior uveal melanoma in young patients treated with proton beam therapy.
    Vavvas D; Kim I; Lane AM; Chaglassian A; Mukai S; Gragoudas E
    Retina; 2010 Sep; 30(8):1267-71. PubMed ID: 20224468
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.